Vaccines for kids, inflation opportunities and Earnings Exchange

The CDC’s advisory panel is just hours away from voting to give Pfizer’s Covid vaccine approval for kids aged 5 to 11. We’ll speak with Pfizer CEO Albert Bourla about that and the strong earnings the company just reported. Plus, our latest CNBC survey shows inflation has eclipsed Covid as the number one threat to our economy. We’ll discuss. And, in today’s Earnings Exchange: we’ll look ahead to Lyft, T-Mobile and Zillow results out after the bell.